Literature DB >> 17252007

CD200 as a prognostic factor in acute myeloid leukaemia.

A Tonks, R Hills, P White, B Rosie, K I Mills, A K Burnett, R L Darley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17252007     DOI： 10.1038/sj.leu.2404559

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  66 in total

1.  Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.

Authors:  Robin Mihrshahi; Marion H Brown
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

2.  The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.

Authors:  Magda Stumpfova; Desirée Ratner; Edward B Desciak; Yehuda D Eliezri; David M Owens
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

Review 3.  Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?

Authors:  Celalettin Ustun; Jeffrey S Miller; David H Munn; Daniel J Weisdorf; Bruce R Blazar
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

4.  The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse.

Authors:  S J Coles; M N Gilmour; R Reid; S Knapper; A K Burnett; S Man; A Tonks; R L Darley
Journal:  Leukemia       Date:  2015-03-09       Impact factor: 11.528

5.  Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.

Authors:  Zhengming Xiong; Elisabet Ampudia-Mesias; Rob Shaver; Craig M Horbinski; Christopher L Moertel; Michael R Olin
Journal:  Immunotherapy       Date:  2016-09       Impact factor: 4.196

6.  Cellular distribution of CD200 receptor in rats and its interaction with cytomegalovirus e127 protein.

Authors:  Mohamed A El-Mokhtar; Agnieszka Bauer; Julia Madela; Sebastian Voigt
Journal:  Med Microbiol Immunol       Date:  2018-07-21       Impact factor: 3.402

7.  Merkel cell carcinoma expresses the immunoregulatory ligand CD200 and induces immunosuppressive macrophages and regulatory T cells.

Authors:  Maria Rita Gaiser; Cleo-Aron Weis; Timo Gaiser; Hong Jiang; Kristina Buder-Bakhaya; Esther Herpel; Arne Warth; Ying Xiao; Lingling Miao; Isaac Brownell
Journal:  Oncoimmunology       Date:  2018-02-08       Impact factor: 8.110

Review 8.  Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.

Authors:  Shernan G Holtan; Douglas J Creedon; Paul Haluska; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

9.  The rhesus rhadinovirus CD200 homologue affects immune responses and viral loads during in vivo infection.

Authors:  Ryan D Estep; Stephanie D Rawlings; Helen Li; Minsha Manoharan; Elizabeth T Blaine; Megan A O'Connor; Ilhem Messaoudi; Michael K Axthelm; Scott W Wong
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

10.  Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells.

Authors:  Robin Mihrshahi; A Neil Barclay; Marion H Brown
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.